Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,140 INR | +2.18% | +3.73% | +7.93% |
May. 30 | Advent International Receives 6-7 Bids for Bharat Serums | CI |
May. 16 | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 |
Sales 2024 | 103B 1.24B | Sales 2025 * | 116B 1.39B | Capitalization | 857B 10.28B |
---|---|---|---|---|---|
Net income 2024 | 19.13B 229M | Net income 2025 * | 22.08B 265M | EV / Sales 2024 | 8.92 x |
Net cash position 2024 * | 25.25B 303M | Net cash position 2025 * | 43.55B 522M | EV / Sales 2025 * | 6.99 x |
P/E ratio 2024 |
48.3
x | P/E ratio 2025 * |
38.8
x | Employees | 18,468 |
Yield 2024 * |
0.29% | Yield 2025 * |
0.41% | Free-Float | 19.92% |
Latest transcript on Mankind Pharma Limited
1 day | +2.18% | ||
1 week | +3.73% | ||
1 month | -9.50% | ||
3 months | -0.45% | ||
6 months | +11.79% | ||
Current year | +7.93% |
Managers | Title | Age | Since |
---|---|---|---|
Sheetal Arora
CEO | Chief Executive Officer | 48 | 07-09-20 |
Ashutosh Dhawan
DFI | Director of Finance/CFO | 55 | 16-06-16 |
Pradeep Chugh
CMP | Compliance Officer | - | 16-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivek Kalra
BRD | Director/Board Member | 60 | 22-07-31 |
Vijaya Sampath
BRD | Director/Board Member | 71 | 22-07-31 |
Surendra Lunia
BRD | Director/Board Member | 61 | 15-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2,140 | +2.18% | 13,650,650 |
24-05-30 | 2,094 | -0.39% | 1,342,025 |
24-05-29 | 2,102 | -0.57% | 781,782 |
24-05-28 | 2,114 | +0.00% | 610,496 |
24-05-27 | 2,114 | +2.50% | 959,693 |
Delayed Quote NSE India S.E., May 31, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.93% | 10.27B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- MANKIND Stock